A Comparative Cross-sectional Study of Psychological Distress, Fatigue, and Physical Activity in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Sjögren's Disease

Overview

Journal Front Med (Lausanne)

Date 2025 Jan 23

PMID 39845811

Authors

Sonja Beider

Michael Stephan

Tabea Seeliger

Thomas Skripuletz

Torsten Witte

Diana Ernst

Affiliations

Soon will be listed here.

Abstract

Introduction: Anxiety and depression are common in patients with rheumatic diseases, but their impact across conditions like rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and primary Sjögren's disease (SjD) is still not well understood. This study aims to compare depression, anxiety, and fatigue, and their effects on disease activity and physical activity in these conditions.

Methods: From January 2019 to March 2021, patients with RA, primary SjD and SLE were assessed consecutively in a monocentric cross-sectional study at the rheumatology outpatient clinic of the Hannover Medical School. Standardized questionnaires were used to assess depression, anxiety, fatigue, disease activity, functional impairment, and physical activity in these patients.

Results: Of 445 patients, 36.9% had RA, 32.8% SLE, and 30.3% SjD, with most being female (RA 76.2%, SLE 85.6%, SjD 87.4%). Depression (28.5%) and anxiety (31.2%) were common, particularly in SLE (28.8%) and SjD (36.3%) vs. RA (22%, 0.002). Physical inactivity was higher in SLE (44.5%) and SjD (44.4%) than in RA (39.0%), especially in depressed patients ( 0.011). A significant proportion of patients retired early, especially in SLE (85%) and SjD (66%) vs. RA (49%, 0.001). Disease activity correlated with psychological status ( < 0.05).

Conclusions: Depression and anxiety are highly prevalent in RA, SLE, and SjD, particularly in SLE and SjD. The study highlights the need for early psychological evaluation and integrated care involving rheumatologists and mental health professionals to address these issues and improve physical and mental well-being.

References

Hinz A, Brahler E . Normative values for the hospital anxiety and depression scale (HADS) in the general German population. J Psychosom Res. 2011; 71(2):74-8. DOI: 10.1016/j.jpsychores.2011.01.005. View

Xie X, Wu D, Chen H . Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China. Rheumatol Int. 2016; 36(12):1705-1710. DOI: 10.1007/s00296-016-3559-3. View

Monahan R, Beaart-van de Voorde L, Eikenboom J, Fronczek R, Kloppenburg M, Middelkoop H . Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity. Lupus. 2021; 30(7):1124-1132. PMC: 8120630. DOI: 10.1177/09612033211005014. View

Azizli A, Sargin G, Senturk T . The effect of disease-modifying antirheumatic drugs on sleep and quality of life in older patients with rheumatoid arthritis. J Rheum Dis. 2023; 30(2):99-105. PMC: 10324934. DOI: 10.4078/jrd.22.0053. View

Hu H, Xu A, Gao C, Wang Z, Wu X . The effect of physical exercise on rheumatoid arthritis: An overview of systematic reviews and meta-analysis. J Adv Nurs. 2020; 77(2):506-522. DOI: 10.1111/jan.14574. View

Beider S, Flohr S, Gehlert S, Witte T, Ernst D . . Z Rheumatol. 2021; . DOI: 10.1007/s00393-021-01066-4. View

Kramer E, Seeliger T, Skripuletz T, Godecke V, Beider S, Jablonka A . Multimodal Assessment and Characterization of Sicca Syndrome. Front Med (Lausanne). 2022; 8:777599. PMC: 8714883. DOI: 10.3389/fmed.2021.777599. View

Lim E, Ahn Y, Jang E, Lee S, Lee S, Son C . Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020; 18(1):100. PMC: 7038594. DOI: 10.1186/s12967-020-02269-0. View

Liu L, Xu X, Xu N, Wang L . Disease activity, resilience and health-related quality of life in Chinese patients with rheumatoid arthritis: a multi-center, cross-sectional study. Health Qual Life Outcomes. 2017; 15(1):149. PMC: 5525274. DOI: 10.1186/s12955-017-0725-6. View

10.

Hewlett S, Choy E, Kirwan J . Furthering our understanding of fatigue in rheumatoid arthritis. J Rheumatol. 2012; 39(9):1775-7. DOI: 10.3899/jrheum.120724. View

11.

Charalambous A, Giannakopoulou M, Bozas E, Paikousis L . Parallel and serial mediation analysis between pain, anxiety, depression, fatigue and nausea, vomiting and retching within a randomised controlled trial in patients with breast and prostate cancer. BMJ Open. 2019; 9(1):e026809. PMC: 6347855. DOI: 10.1136/bmjopen-2018-026809. View

12.

Segal B, Bowman S, Fox P, Vivino F, Murukutla N, Brodscholl J . Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009; 7:46. PMC: 2693523. DOI: 10.1186/1477-7525-7-46. View

13.

Verstappen S, Bijlsma J, Verkleij H, Buskens E, Blaauw A, ter Borg E . Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004; 51(3):488-97. DOI: 10.1002/art.20419. View

14.

Al Dhanhani A, Gignac M, Su J, Fortin P . Work disability in systemic lupus erythematosus. Arthritis Rheum. 2009; 61(3):378-85. DOI: 10.1002/art.24347. View

15.

Anyfanti P, Gavriilaki E, Pyrpasopoulou A, Triantafyllou G, Triantafyllou A, Chatzimichailidou S . Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated. Clin Rheumatol. 2014; 35(3):733-9. DOI: 10.1007/s10067-014-2677-0. View

16.

Hernandez-Hernandez M, Diaz-Gonzalez F . Role of physical activity in the management and assessment of rheumatoid arthritis patients. Reumatol Clin. 2016; 13(4):214-220. DOI: 10.1016/j.reuma.2016.04.003. View

17.

Schneider M, Haupt M . [Overcoming disease in systemic lupus erythematosus]. Z Rheumatol. 2015; 74(7):591-6. DOI: 10.1007/s00393-014-1556-z. View

18.

Baerwald C, Manger B, Hueber A . [Depression as comorbidity of rheumatoid arthritis]. Z Rheumatol. 2018; 78(3):243-248. DOI: 10.1007/s00393-018-0568-5. View

19.

. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. PMC: 5605509. DOI: 10.1016/S0140-6736(17)32154-2. View

20.

Jacobi F, Hofler M, Siegert J, Mack S, Gerschler A, Scholl L . Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res. 2014; 23(3):304-19. PMC: 6878234. DOI: 10.1002/mpr.1439. View